CAS 71109-09-6
:Védaprofène
- (+-)-4-Cyclohexyl-alpha-methyl-1-naphthaleneacetic acid
- 1-Naphthaleneacetic acid, 4-cyclohexyl-alpha-methyl-, (+-)-
- 1-Naphthaleneacetic acid, 4-cyclohexyl-α-methyl-
- 2-(1-Cyclohexylnaphthalen-4-yl)propanoic acid
- 2-(4-Cyclohexylnaphthalen-1-Yl)Propanoic Acid
- 4-Cyclohexyl-alpha-methylnaphthalene-1-acetic acid
- 4-Cyclohexyl-Α-Methylnaphthalene-1-Acetic Acid
- 4-Cyclohexyl-α-methyl-1-naphthaleneacetic acid
- Cerm 10202
- Pm 150
- Quadrisol
- Unii-Okx88Eo7Oi
- Vedaprofen [USAN:INN:BAN]
- Voir plus de synonymes
VEDAPROFEN CRS
CAS :VEDAPROFEN CRSFormule :C19H22O2Couleur et forme :Powder.Masse moléculaire :282.37681-Naphthaleneaceticacid, 4-cyclohexyl-a-methyl-
CAS :Formule :C19H22O2Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :282.3768Vedaprofen
CAS :Vedaprofen (PM 150) is a COX-1 inhibitor with anti-inflammatory effects, blocking E. coli clamp at IC50 222 μM, Ki 131 μM.
Formule :C19H22O2Degré de pureté :99.24% - 99.70%Couleur et forme :SolidMasse moléculaire :282.38Vedaprofen 100 µg/mL in Acetonitrile
CAS :Formule :C19H22O2Couleur et forme :Single SolutionMasse moléculaire :282.38Vedaprofen
CAS :Applications Propionic acid type non-steroidal anti-inflammatory drug (NSAID).
References Mitchell, J., et al.: Biochem. Pharmacol., 50, 1535 (1995), Haak, T., et al.: Clin. Exp. Rheumatol., 14(6), 633 (1996), Lees, P., et al.: J. Vet. Pharmacol. Ther., 22, 96 (1999), Hawkey, C., et al.: Arthritis Rheum., 43, 370 (2000),Formule :C19H22O2Couleur et forme :White To BrownMasse moléculaire :282.38Vedaprofen
CAS :Vedaprofen is a nonsteroidal anti-inflammatory drug that belongs to the class of drugs known as NSAIDs. It inhibits the activity of the enzyme cyclooxygenase (COX), which causes inflammation and pain. Vedaprofen has been shown to be effective in treating bowel disease, inflammatory bowel disease, and autoimmune diseases, such as arthritis. Vedaprofen also has antimicrobial properties, inhibiting bacterial growth by binding to the COX enzyme in the cell membrane. The α subunit is one of the effector proteins for COX-1 and COX-2, and vedaprofen binds to this protein preventing its activation. This inhibitory effect on COX-1 and COX-2 leads to a reduction in production of prostaglandins (PGs) that are responsible for inflammatory responses. Vedaprofen may be administered orally or intravenously depending on the severity of symptoms. The oral route is preferred because it does not require
Formule :C19H22O2Degré de pureté :Min. 95%Masse moléculaire :282.38 g/mol








